News, Analysis & Insights on Nutrition, Supplements, and Health
For centuries, coca leaf has played an important cultural and traditional role in the Andes. But outside South America, the plant is far more likely to be associated with one thing: cocaine. So what happens when we separate the coca leaf from the drug...
FDA wants companies to notify the agency when they determine food ingredients are Generally Recognized As Safe. But with hundreds of potential notifications and fewer staff, questions remain over whether FDA has the resources to review them
The UK’s B-12 Alliance will take to parliament on September 10 as part of its campaign to raise awareness of widespread vitamin B12 deficiency and improve diagnosis and treatment in the UK.
Synthetic spokespeople may be new, but industry experts say brands remain responsible for substantiated claims, truthful endorsements and transparent marketing.
The dietary supplement industry is facing a new layer of supply-chain uncertainty as geopolitical tensions, tariffs, energy prices and freight disruptions ripple through the global ingredient market.
Dr. Heidi Overton was nominated by President Donald Trump to lead the Food and Drug Administration, the White House announced Wednesday.
The EU has confirmed that traditional Echinacea roots, herbs and teas are non-novel, but uncertainty remains around flowers, whole-plant preparations and the species Echinacea pallida.
Quten Research Institute is facing a proposed class action alleging that its Qunol Ultra Omega-3 Fish Oil contains less omega-3 than the 1,000 mg advertised on the product label.
Connected wellness products offer supplement companies opportunities to reach beyond traditional categories, but that move may also expose them to new safety requirements and closer regulatory scrutiny.
A new ruling from the Advertising Standards Authority (ASA) over The Turmeric Co.’s use of blurred customer testimonials reinforces the agency’s strict stance on disease claims, reminding the industry that even implied treatment claims are off-limits.
Stricter GMP laws in South Korea, notice against NMN use in India and a new policy draft on probiotic use in China are some of the latest updates in this regulatory news round-up.
Venable’s Todd Harrison questions FDA’s authority to mandate Generally Recognized As Safe (GRAS) notifications and says the proposal could create significant uncertainty for ingredient suppliers and functional food and beverage companies.
The dispute highlights how competing measures of market leadership can determine which supplement brands are able to claim the top spot.
The latest developments in consumer trends, scientific research, innovations and regulatory oversight in Asia-Pacific’s healthspan and longevity sector will be discussed in an upcoming webinar on August 27.
Canomiks’ evidence-based platform aims to help consumers distinguish product-specific science from marketing claims while encouraging greater transparency across the dietary supplement industry.
South Korea’s Ministry of Food and Drug Safety (MFDS) is drafting new rules to tighten Good Manufacturing Practice (GMP) standards, as well as labeling requirements for customized health functional foods, with public feedback accepted until August 31.
Ryse Up Sports Nutrition is facing a proposed class action alleging its Ryse Clear Protein Drinks contain between 6% and 11% less protein than the 22 g declared on the label.
The sports nutrition industry has a responsibility to tackle the ‘more is better’ mindset through appropriate limits and warnings, experts warn, following a life-threatening case of supplement stacking and over-consumption.
Nicotinamide mononucleotide (NMN) is an unapproved ingredient, the Food Safety and Standards Authority of India (FSSAI) has stated in a notice sent to two companies based in Gujarat, India.
The proposed legislation would establish a federal regulatory framework for hemp-derived cannabinoid products, which industry stakeholders say could provide long-sought regulatory certainty for manufacturers and create a clearer pathway for nutrition and...
The threshold for vitamin D deficiency in the UK should be doubled in order to rouse officials to take a preventative approach to health, according to a newly published paper by the health and nutrition expert working group ‘Act Now Vitamin D’.
The UK advertising agency, the Advertising Standards Authority (ASA), has ruled against Exhale Coffee after finding that the brand made unauthorized longevity and anti-aging claims.
The Nutra Healthspan Summit will land in London once again this November, bringing together leading academics, innovators, analysts and practitioners in the longevity space.
The United States Patent and Trademark Office has issued The Akkermansia Company (TAC) with a new patent, granting the company the exclusive right to market Akkermansia for metabolic disorders.
In response, TruHeight stated it has already implemented broader compliance measures, including external regulatory oversight and updated review policies.
The European Commission has approved Eggnovo’s enzymatically produced eggshell membrane (ESM) hydrolysate as a novel food for use in food supplements across the EU.
Catch up with our weekly round-up of key news from across the Nutraverse.
The UK’s Novel Foods Experts Network (NFX UK) has secured $650,000 to strengthen its innovation ecosystem and expand its support across Europe.
New developments on ashwagandha regulatory assessment and Singapore’s proposal for mandatory health supplements notification are some of the latest updates in this regulatory news round-up.